|
|
||||||||
Departments of Neurology (Drs. Fadul, Wood, and Posner), Neurosurgery (Drs. Galicich and Patterson), and Biostatistics (Dr. Thaler), Memorial Sloan-Kettering Cancer Center and New York Hospital-Cornell University Medical College, New York, NY. Dr. Fadul's current address is Institute Nacionale de Cancerologia, Bogota, Colombia.
Extensive surgical resection of supratentorial gliomas increases survival. However, some reports suggest that the perioperative morbidity and mortality outweigh the potential benefit of the procedure. We examined prospectively morbidity and mortality in 104 consecutive patients who underwent surgery for supratentorial glioma, as well as other factors that might affect the short-term outcome. To determine if our experience was unusual, we compared these results with those obtained from another academic neurosurgical center by a review of the records of 109 patients also treated surgically for supratentorial glioma. Mortality was 3.3% and the medical plus neurologic morbidity was 31.7%. Functionally significant neurologic worsening occurred in 42 (19.7%) patients. Complications were more frequent in patients with moderate or severe preoperative disabilities than those with mild or no preoperative disability. Patients with complete resection had fewer acute neurologic complications, and no greater risk of being neurologically impaired at 1 week, than patients with biopsy or less extensive procedures. Morbidity and mortality correlated with location: deep-midline lesions had a higher overall rate of perioperative complications (p = 0.032) and mortality (p = 0.019) and bilateral lesions a higher rate of hemorrhage (p = 0.017) and hydrocephalus (p = 0.010). Older patients (>55 years) and those receiving high daily dose of preoperative dexamethasone (
24 mg) had a significantly higher risk of surgical mortality. Reoperation for recurrent tumor carried no greater risk of mortality, neurologic deterioration, and infection than a first operation. Whenever possible, maximal surgical resection should be offered to patients with supratentorial gliomas, because it does not carry a higher surgical risk than biopsy, and the long-term outcome is superior.
Address correspondence and reprint requests to Dr. Posner, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021.
Received November 5, 1987. Accepted for publication in final form January 18, 1988.
This article has been cited by other articles:
![]() |
M. Kocak, J. L. Ulmer, M. Sahin Ugurel, W. Gaggl, and R. W. Prost Motor Homunculus: Passive Mapping in Healthy Volunteers by Using Functional MR Imaging--Initial Results Radiology, May 1, 2009; 251(2): 485 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen Clinical Applications of PET in Brain Tumors J. Nucl. Med., September 1, 2007; 48(9): 1468 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Duffau, M Lopes, F Arthuis, A Bitar, J-P Sichez, R Van Effenterre, and L Capelle Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985-96) and with (1996-2003) functional mapping in the same institution J. Neurol. Neurosurg. Psychiatry, June 1, 2005; 76(6): 845 - 851. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Duffau, L Capelle, D Denvil, N Sichez, P Gatignol, M Lopes, M-C Mitchell, J-P Sichez, and R Van Effenterre Functional recovery after surgical resection of low grade gliomas in eloquent brain: hypothesis of brain compensation J. Neurol. Neurosurg. Psychiatry, July 1, 2003; 74(7): 901 - 907. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Jackson, G. N. Fuller, D. Abi-Said, F. F. Lang, Z. L. Gokaslan, W. M. Shi, D. M. Wildrick, and R. Sawaya Limitations of stereotactic biopsy in the initial management of gliomas Neuro-oncol, July 1, 2001; 3(3): 193 - 200. [Abstract] [PDF] |
||||
![]() |
L. M. DeAngelis Brain Tumors N. Engl. J. Med., January 11, 2001; 344(2): 114 - 123. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |